Sir Pascal Soriot
Sir Pascal Soriot is the Chief Executive Officer of AstraZeneca, a global biopharmaceutical company. Under his leadership, AstraZeneca has focused on innovation and research in drug development, particularly in oncology and respiratory diseases. Soriot has emphasized the growing importance of China in the pharmaceutical sector, predicting that the nation will become a major player in drug innovation over the next decade. His insights reflect a broader trend in the industry, as companies increasingly look to China for new opportunities and advancements in medicine.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Australia | 1 | 8.00 | 0.05% | +0% | 25,499,884 | 13,316 | $1,380,000 | 721$ |
| Totals | 1 | 25,499,884 | 13,316 | $1,380,000 | 721$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Sir Pascal Soriot, the boss of AstraZeneca, said in March that China is going to emerge as a driving force for innovation in the sector.
8